N. Astam Et Al. , "Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion," International Ophthalmology , vol.29, no.5, pp.343-348, 2009
Astam, N. Et Al. 2009. Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion. International Ophthalmology , vol.29, no.5 , 343-348.
Astam, N., ŞERMET, F., & ÖZMERT, E., (2009). Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion. International Ophthalmology , vol.29, no.5, 343-348.
Astam, Neslihan, FİGEN ŞERMET, And EMİN ÖZMERT. "Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion," International Ophthalmology , vol.29, no.5, 343-348, 2009
Astam, Neslihan Et Al. "Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion." International Ophthalmology , vol.29, no.5, pp.343-348, 2009
Astam, N. ŞERMET, F. And ÖZMERT, E. (2009) . "Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion." International Ophthalmology , vol.29, no.5, pp.343-348.
@article{article, author={Neslihan Astam Et Al. }, title={Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion}, journal={International Ophthalmology}, year=2009, pages={343-348} }